Чланци са овлашћеним јавним приступом - Debbie van baarleСазнајте више
Није доступно нигде: 2
γδT cells elicited by CMV reactivation after allo-SCT cross-recognize CMV and leukemia
W Scheper, S van Dorp, S Kersting, F Pietersma, C Lindemans, S Hol, ...
Leukemia 27 (6), 1328-1338, 2013
Овлашћења: German Research Foundation, Dutch Cancer Society
mRNA-based COVID-19 vaccination of lung transplant recipients with prior SARS-CoV-2 infection induces durable SARS-CoV-2-specific antibodies and T cells
S Liu, LLA van Dijk, Y den Hartog, R Hoek, E Verschuuren, ...
Vaccine 42 (24), 126250, 2024
Овлашћења: Netherlands Organisation for Health Research and Development
Доступно негде: 72
VDJdb: a curated database of T-cell receptor sequences with known antigen specificity
M Shugay, DV Bagaev, IV Zvyagin, RM Vroomans, JC Crawford, G Dolton, ...
Nucleic acids research 46 (D1), D419-D427, 2018
Овлашћења: Cancer Research UK, Wellcome Trust, European Commission
Impact of delivery mode-associated gut microbiota dynamics on health in the first year of life
M Reyman, MA van Houten, D van Baarle, AATM Bosch, WH Man, ...
Nature communications 10 (1), 4997, 2019
Овлашћења: Netherlands Organisation for Scientific Research
The RECOVAC immune-response study: the immunogenicity, tolerability, and safety of COVID-19 vaccination in patients with chronic kidney disease, on dialysis, or living with a …
JSF Sanders, FJ Bemelman, AL Messchendorp, CC Baan, D Van Baarle, ...
Transplantation 106 (4), 821-834, 2022
Овлашћења: Netherlands Organisation for Health Research and Development
mRNA-1273 COVID-19 vaccination in patients receiving chemotherapy, immunotherapy, or chemoimmunotherapy for solid tumours: a prospective, multicentre, non-inferiority trial
SF Oosting, AAM van der Veldt, CH GeurtsvanKessel, RSN Fehrmann, ...
The Lancet Oncology 22 (12), 1681-1691, 2021
Овлашћења: European Commission, Netherlands Organisation for Health Research and …
Immunogenicity and reactogenicity of vaccine boosters after Ad26. COV2. S priming
RSG Sablerolles, WJR Rietdijk, A Goorhuis, DF Postma, LG Visser, ...
New England Journal of Medicine 386 (10), 951-963, 2022
Овлашћења: Netherlands Organisation for Health Research and Development
Distribution of immune cells in the human cervix and implications for HIV transmission
RT Trifonova, J Lieberman, D van Baarle
American journal of reproductive immunology 71 (3), 252-264, 2014
Овлашћења: US National Institutes of Health
The hallmarks of CMV-specific CD8 T-cell differentiation
SPH van den Berg, IN Pardieck, J Lanfermeijer, D Sauce, P Klenerman, ...
Medical microbiology and immunology 208, 365-373, 2019
Овлашћења: Netherlands Organisation for Scientific Research, Cancer Research UK …
CMV immune evasion and manipulation of the immune system with aging
SE Jackson, A Redeker, R Arens, D van Baarle, SPH van den Berg, ...
Geroscience 39, 273-291, 2017
Овлашћења: US National Institutes of Health, German Research Foundation, Helmholtz …
Differential gene expression of activating Fcγ receptor classifies active tuberculosis regardless of human immunodeficiency virus status or ethnicity
JS Sutherland, AG Loxton, MC Haks, D Kassa, L Ambrose, JS Lee, L Ran, ...
Clinical microbiology and infection 20 (4), O230-O238, 2014
Овлашћења: UK Medical Research Council, Wellcome Trust
T cell receptor repertoires associated with control and disease progression following Mycobacterium tuberculosis infection
M Musvosvi, H Huang, C Wang, Q Xia, V Rozot, A Krishnan, P Acs, ...
Nature Medicine 29 (1), 258-269, 2023
Овлашћења: Bill & Melinda Gates Foundation, US National Institutes of Health, Howard …
Disruption of circadian rhythm by alternating light‐dark cycles aggravates atherosclerosis development in APOE* 3‐Leiden. CETP mice
M Schilperoort, R van den Berg, LA Bosmans, BW van Os, MET Dollé, ...
Journal of pineal research 68 (1), e12614, 2020
Овлашћења: Netherlands Organisation for Scientific Research, Dutch Heart Foundation
Alternative strategies to increase the immunogenicity of COVID-19 vaccines in kidney transplant recipients not responding to two or three doses of an mRNA vaccine (RECOVAC): a …
MML Kho, AL Messchendorp, SC Frölke, C Imhof, VJCH Koomen, ...
The Lancet Infectious Diseases 23 (3), 307-319, 2023
Овлашћења: Netherlands Organisation for Health Research and Development
Infectious reactivation of cytomegalovirus explaining age-and sex-specific patterns of seroprevalence
M van Boven, J van de Kassteele, MJ Korndewal, CH van Dorp, ...
PLoS computational biology 13 (9), e1005719, 2017
Овлашћења: Netherlands Organisation for Scientific Research
Naive CD8+ T‐cell precursors display structured TCR repertoires and composite antigen‐driven selection dynamics
MA Neller, K Ladell, JE McLaren, KK Matthews, E Gostick, JM Pentier, ...
Immunology and cell biology 93 (7), 625-633, 2015
Овлашћења: National Health and Medical Research Council, Australia, UK Biotechnology …
Immunometabolic signatures predict risk of progression to active tuberculosis and disease outcome
FJ Duffy, J Weiner III, S Hansen, DL Tabb, S Suliman, E Thompson, ...
Frontiers in immunology 10, 527, 2019
Овлашћења: Bill & Melinda Gates Foundation, US National Institutes of Health, UK …
Sequence variations in HIV-1 p24 Gag-derived epitopes can alter binding of KIR2DL2 to HLA-C* 03: 04 and modulate primary natural killer cell function
NH Van Teijlingen, A Hölzemer, C Körner, WF García-Beltrán, JL Schafer, ...
Aids 28 (10), 1399-1408, 2014
Овлашћења: US National Institutes of Health, Doris Duke Charitable Foundation
The RECOVAC IR study: the immune response and safety of the mRNA-1273 COVID-19 vaccine in patients with chronic kidney disease, on dialysis or living with a kidney transplant
MML Kho, MEJ Reinders, CC Baan, D van Baarle, FJ Bemelman, ...
Nephrology Dialysis Transplantation 36 (9), 1761-1764, 2021
Овлашћења: Netherlands Organisation for Health Research and Development
Towards effective and safe immunotherapy after allogeneic stem cell transplantation: identification of hematopoietic-specific minor histocompatibility antigen UTA2-1
R Oostvogels, MC Minnema, M Van Elk, RM Spaapen, GD Te Raa, ...
Leukemia 27 (3), 642-649, 2013
Овлашћења: Dutch Cancer Society
Публикације и информације о финансирању аутоматски одређује рачунарски програм